GlassBury AI combines agentic patient matching with culturally sensitive community education to eliminate healthcare disparities. By pairing AI with expert-curated workshops, we build the trust necessary to connect underrepresented patients with life-changing clinical trials.
A Drop in the Bucket: Blood Tests and the Evolving Landscape of Alzheimer's Diagnosis
The world of Alzheimer's research is constantly evolving, a relentless pursuit of unraveling the complexities of this devastating neurodegenerative disease. Just recently, a significant milestone was reached, one that could potentially reshape the way we approach diagnosis. The Food and Drug Administration (FDA)
The Titans of Memory: Inside the Top 7 Organizations Fighting Alzheimer’s Disease
Alzheimer’s research in the United States is a massive, multi-billion-dollar ecosystem. It is led by a powerful and highly coordinated mix of federal government agencies, non-profit foundations, and elite academic medical centers.
Lecanemab Real-World Safety: Duke Health Study Insights for Alzheimer’s Patients
For decades, the search for a way to slow down Alzheimer’s disease felt like chasing a horizon that never got closer. However, the arrival of anti-amyloid therapies like lecanemab has shifted the conversation from "what if" to "how." While clinical trials provide a controlled environment to test these drugs
The Ripple Effect of Altruism: Why Unconditional Love Matters
In today's fast-paced, self-centered world, it's easy to get caught up in the pursuit of personal gain and happiness. We are constantly bombarded with messages promoting individual success and the accumulation of wealth and possessions. However, amidst this relentless focus on self, there's a growing recognition of the transformative power of altruism – the selfless act of caring for others without expecting anything in return. In this blog post, we will explore the profound impact of altruistic love and why it is essential for building a more compassionate and fulfilling world.
A Son's Reflections on Caring for His Dying Mother by Corey Hubbard
When I first became a caregiver for my terminally ill mother, I was thrust into a world I was wholly unprepared for. The woman who had always been my pillar of strength, my source of unwavering support, was now vulnerable and dependent on me.
AI Meets the Genome: The September 2026 Breakthroughs Decoding Alzheimer’s
Discover how AI models analyzing structural 3D genome folding and speech biometrics published in mid-September 2026 are cracking Alzheimer's mysteries.
Introduction: Is Fish Really the Ultimate "Brain Food"?
A study published in the American Journal of Epidemiology (August 2026) addressed this question. Researchers tracked cognitively healthy older adults over a 21-year period to evaluate how consistent, sustained fish consumption influences the long-term risk of developing Alzheimer's disease.